2021 Q3 Form 10-Q Financial Statement

#000163297021000113 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3
Revenue $37.21M $18.95M
YoY Change 96.38% -39.11%
Cost Of Revenue $14.54M $17.40M
YoY Change -16.42% 252.95%
Gross Profit $22.67M $1.551M
YoY Change 1361.64% -94.08%
Gross Profit Margin 60.92% 8.19%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.181M $7.966M
YoY Change 2.7% 17.04%
% of Gross Profit 36.09% 513.6%
Operating Expenses
YoY Change
Operating Profit $52.48M
YoY Change
Interest Expense $4.961M $4.839M
YoY Change 2.52% 16.88%
% of Operating Profit 9.45%
Other Income/Expense, Net -$3.329M -$6.822M
YoY Change -51.2% -248.05%
Pretax Income -$5.898M -$5.191M
YoY Change 13.62% 171.64%
Income Tax $0.00 -$39.00K
% Of Pretax Income
Net Earnings -$5.777M -$4.920M
YoY Change 17.42% 159.08%
Net Earnings / Revenue -15.53% -25.97%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$0.03
COMMON SHARES
Basic Shares Outstanding 179.6M shares
Diluted Shares Outstanding 179.6M shares

Balance Sheet

Concept 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $16.18M $22.69M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $54.75M $68.64M
YoY Change -20.23% -6.52%
Long-Term Investments $45.63M $47.97M
YoY Change -4.88% 1.42%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.064B $1.111B
YoY Change -4.28% 7.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $546.0M $549.6M
YoY Change -0.66% 25.13%
SHAREHOLDERS EQUITY
Retained Earnings -$222.8M -$172.4M
YoY Change 29.19% 43.88%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $514.8M $558.3M
YoY Change
Total Liabilities & Shareholders Equity $1.064B $1.111B
YoY Change -4.28% 7.12%

Cashflow Statement

Concept 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$5.777M -$4.920M
YoY Change 17.42% 159.08%
Depreciation, Depletion And Amortization $8.181M $7.966M
YoY Change 2.7% 17.04%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001632970
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55775
dei Entity Registrant Name
EntityRegistrantName
AMERICAN HEALTHCARE REIT, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2887436
dei Entity Address Address Line1
EntityAddressAddressLine1
18191 Von Karman Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
270-9200
dei Entity Information Former Legal Or Registered Name
EntityInformationFormerLegalOrRegisteredName
Griffin-American Healthcare REIT IV, Inc.
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
907103000 USD
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
921580000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16183000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17411000 USD
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
986000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
714000 USD
CY2021Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
2086000 USD
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
2635000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
54752000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
64101000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14043000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14133000 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
68743000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
72199000 USD
CY2021Q3 us-gaap Assets
Assets
1063896000 USD
CY2020Q4 us-gaap Assets
Assets
1092773000 USD
CY2021Q3 us-gaap Secured Debt
SecuredDebt
17409000 USD
CY2020Q4 us-gaap Secured Debt
SecuredDebt
17827000 USD
CY2021Q3 us-gaap Line Of Credit
LineOfCredit
488900000 USD
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
476900000 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
21897000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
23057000 USD
CY2021Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
324000 USD
CY2020Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1046000 USD
CY2021Q3 us-gaap Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
1115000 USD
CY2020Q4 us-gaap Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
1295000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
10021000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
9904000 USD
CY2021Q3 us-gaap Other Liabilities
OtherLiabilities
6300000 USD
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
10387000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
545966000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
540416000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
2592000 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
2618000 USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
736756000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
733192000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-222775000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-185047000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
514798000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
548958000 USD
CY2021Q3 us-gaap Minority Interest
MinorityInterest
540000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
781000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
515338000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
549739000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1063896000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1092773000 USD
CY2021Q3 us-gaap Line Of Credit
LineOfCredit
488900000 USD
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
476900000 USD
CY2021Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
22120000 USD
CY2020Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
21519000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
66054000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
64824000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15090000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18948000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46179000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51863000 USD
CY2021Q3 ahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
0 USD
CY2020Q3 ahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
864000 USD
ahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
0 USD
ahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
864000 USD
CY2021Q3 ahr Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
37210000 USD
CY2020Q3 ahr Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
41331000 USD
ahr Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
112233000 USD
ahr Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
117551000 USD
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
6389000 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
5905000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
18542000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
17723000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14540000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17397000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
44179000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
44856000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4304000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3672000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11710000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11960000 USD
CY2021Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3800000 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
57000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6552000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
74000 USD
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10746000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12669000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
33745000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
37919000 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
39779000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
39700000 USD
us-gaap Costs And Expenses
CostsAndExpenses
114728000 USD
us-gaap Costs And Expenses
CostsAndExpenses
112532000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
4961000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
4839000 USD
us-gaap Interest Expense
InterestExpense
14556000 USD
us-gaap Interest Expense
InterestExpense
15123000 USD
CY2021Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
1514000 USD
CY2020Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
1450000 USD
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
4431000 USD
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-2302000 USD
CY2021Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2020Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
3064000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
3064000 USD
CY2021Q3 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
15000 USD
CY2020Q3 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-184000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
70000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-377000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1027000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
952000 USD
CY2021Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
33000 USD
CY2020Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
8000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
49000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
278000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3329000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6822000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11287000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19259000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5898000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5191000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13782000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14240000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14240000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-39000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-5898000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-5152000 USD
us-gaap Profit Loss
ProfitLoss
-13782000 USD
us-gaap Profit Loss
ProfitLoss
-14240000 USD
us-gaap Profit Loss
ProfitLoss
-14240000 USD
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-121000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-232000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-489000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-608000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-5777000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4920000 USD
us-gaap Net Income Loss
NetIncomeLoss
-13293000 USD
us-gaap Net Income Loss
NetIncomeLoss
-13632000 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
44000 USD
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
81704261 shares
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
80788359 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
81635053 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
80498693 shares
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
529462000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
21000 USD
CY2021Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
7000 USD
CY2021Q3 ahr Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests
AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests
92000 USD
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2021Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8239000 USD
CY2021Q3 ahr Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend
NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend
-5807000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
515338000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
569002000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
5000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
4247000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
29000 USD
ahr Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend
NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend
-13472000 USD
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
706000 USD
CY2020Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
22000 USD
CY2020Q3 ahr Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests
AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests
208000 USD
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8150000 USD
CY2020Q3 ahr Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend
NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend
-5025000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
559216000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
549739000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
5000 USD
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
5499000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
105000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1874000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
62000 USD
ahr Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests
AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests
167000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
24435000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
515338000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
590079000 USD
ahr Adjustments To Additional Paid In Capital Stock Issued Offering Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedOfferingCosts
-67000 USD
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
15681000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
43000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
128000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5349000 USD
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
1250000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
54000 USD
ahr Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests
AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests
530000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.35
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
28191000 USD
ahr Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend
NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend
-13908000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
559216000 USD
CY2021Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-91000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-127000 USD
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-310000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-332000 USD
us-gaap Profit Loss
ProfitLoss
-13782000 USD
us-gaap Profit Loss
ProfitLoss
-14240000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33745000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37919000 USD
ahr Other Amortization
OtherAmortization
2099000 USD
ahr Other Amortization
OtherAmortization
2084000 USD
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-2707000 USD
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-3440000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
105000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
171000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-184000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1027000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
952000 USD
us-gaap Increase Decrease In Other Financial Instruments Used In Operating Activities
IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities
4431000 USD
us-gaap Increase Decrease In Other Financial Instruments Used In Operating Activities
IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities
-2302000 USD
us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
6196000 USD
us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
0 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
3064000 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-533000 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-1347000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2829000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1654000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3805000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3436000 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-921000 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
27000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
309000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
306000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
37000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
185000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16556000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29943000 USD
us-gaap Payments To Acquire And Develop Real Estate
PaymentsToAcquireAndDevelopRealEstate
3385000 USD
us-gaap Payments To Acquire And Develop Real Estate
PaymentsToAcquireAndDevelopRealEstate
68032000 USD
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
4384000 USD
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
6729000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1573000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-74761000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
475000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
8166000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
17000000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
140800000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
5000000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
58100000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
43000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3940000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4876000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
21700000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
13932000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1874000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5349000 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
1250000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
62000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
54000 USD
ahr Proceedsfrom Redeemable Noncontrolling Interests
ProceedsfromRedeemableNoncontrollingInterests
125000 USD
ahr Proceedsfrom Redeemable Noncontrolling Interests
ProceedsfromRedeemableNoncontrollingInterests
1118000 USD
ahr Paymentsto Redeemable Noncontrolling Interest
PaymentstoRedeemableNoncontrollingInterest
8000 USD
ahr Paymentsto Redeemable Noncontrolling Interest
PaymentstoRedeemableNoncontrollingInterest
81000 USD
ahr Payments For Proceeds From Security Deposits Financing Activities
PaymentsForProceedsFromSecurityDepositsFinancingActivities
-5000 USD
ahr Payments For Proceeds From Security Deposits Financing Activities
PaymentsForProceedsFromSecurityDepositsFinancingActivities
-199000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15939000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52368000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-956000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7550000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18125000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15846000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17169000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23396000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17411000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15290000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
714000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
556000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18125000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15846000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16183000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22690000 USD
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
986000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
706000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17169000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23396000 USD
us-gaap Interest Paid Net
InterestPaidNet
13116000 USD
us-gaap Interest Paid Net
InterestPaidNet
13777000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
51000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
88000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3720000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2182000 USD
ahr Tenant Improvement Overage
TenantImprovementOverage
303000 USD
ahr Tenant Improvement Overage
TenantImprovementOverage
636000 USD
ahr Noncash Or Part Noncash Acquisitions And Disposals Increase Decrease In Other Assets
NoncashOrPartNoncashAcquisitionsAndDisposalsIncreaseDecreaseInOtherAssets
-16000 USD
ahr Noncash Or Part Noncash Acquisitions And Disposals Increase Decrease In Other Assets
NoncashOrPartNoncashAcquisitionsAndDisposalsIncreaseDecreaseInOtherAssets
196000 USD
ahr Noncash Or Part Noncash Acquisitions And Disposals Increase Decrease In Accounts Payable And Accrued Expenses
NoncashOrPartNoncashAcquisitionsAndDisposalsIncreaseDecreaseInAccountsPayableAndAccruedExpenses
-50000 USD
ahr Noncash Or Part Noncash Acquisitions And Disposals Increase Decrease In Accounts Payable And Accrued Expenses
NoncashOrPartNoncashAcquisitionsAndDisposalsIncreaseDecreaseInAccountsPayableAndAccruedExpenses
201000 USD
us-gaap Noncash Or Part Noncash Acquisition Other Liabilities Assumed1
NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1
10000 USD
us-gaap Noncash Or Part Noncash Acquisition Other Liabilities Assumed1
NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1
11000 USD
us-gaap Stock Issued1
StockIssued1
5499000 USD
us-gaap Stock Issued1
StockIssued1
15681000 USD
CY2021Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0 USD
CY2020Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
2664000 USD
CY2021Q3 ahr Accruedstockholderservicingfee
Accruedstockholderservicingfee
2157000 USD
CY2020Q3 ahr Accruedstockholderservicingfee
Accruedstockholderservicingfee
7667000 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. Organization and Description of Business </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Healthcare REIT, Inc. (formerly known as Griffin-American Healthcare REIT IV, Inc.), a Maryland corporation, invests in a diversified portfolio of healthcare real estate properties, focusing primarily on medical office buildings, skilled nursing facilities and senior housing facilities that produce current income. We also operate healthcare-related facilities utilizing the structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, which is commonly referred to as a “RIDEA” structure (the provisions of the Internal Revenue Code of 1986, as amended, or the Code, authorizing the RIDEA structure were enacted as part of the Housing and Economic Recovery Act of 2008). We qualified to be taxed as a real estate investment trust, or REIT, under the Code for federal income tax purposes beginning with our taxable year ended December 31, 2016, and we intend to continue to qualify to be taxed as a REIT.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We raised $754,118,000 through a best efforts initial public offering, or our initial offering, that commenced on February 16, 2016, and issued 75,639,681 aggregate shares of our Class T and Class I common stock. In addition, during our initial offering, we issued 3,253,535 aggregate shares of our Class T and Class I common stock pursuant to our distribution reinvestment plan, as amended, or the DRIP, for a total of $31,021,000 in distributions reinvested. Following the termination of our initial offering on February 15, 2019, we continued issuing shares of our common stock pursuant to the DRIP through a subsequent offering, or the 2019 DRIP Offering, which commenced on March 1, 2019. On March 18, 2021, our board of directors, or our board, authorized the suspension of the DRIP, effective as of April 1, 2021. As of September 30, 2021, a total of $46,970,000 in distributions were reinvested that resulted in 4,923,550 shares of our common stock being issued pursuant to the 2019 DRIP Offering. We collectively refer to the DRIP portion of our initial offering and the 2019 DRIP Offering as our DRIP Offerings. See Note 12, Equity — Distribution Reinvestment Plan, for a further discussion. On October 4, 2021, our board authorized the reinstatement of the DRIP. See Note 20, Subsequent Events —</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinstatement of the DRIP, for a further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until October 1, 2021, we conducted substantially all of our operations through Griffin-American Healthcare REIT IV Holdings, LP, or our operating partnership. Through September 30, 2021, we were externally advised by Griffin-American Healthcare REIT IV Advisor, LLC, or our advisor, pursuant to an advisory agreement, as amended, or the Advisory Agreement, between us, our operating partnership and our advisor. The Advisory Agreement was effective as of February 16, 2016 and had a one-year initial term, subject to successive one-year renewals upon the mutual consent of the parties. The Advisory Agreement was last renewed pursuant to the mutual consent of the parties on February 11, 2021. On June 23, 2021, in anticipation of the Merger, as defined and discussed below, we entered into an amendment to the Advisory Agreement, whereby it was agreed that any acquisition fee due to our advisor is to be waived in connection with the REIT Merger, as defined and discussed below. Except as set forth in such amendment to the Advisory Agreement, the terms of the Advisory Agreement continued in full force and effect. Our advisor used its best efforts, subject to the oversight and review of our board, to, among other things, provide asset management, property management, acquisition, disposition and other advisory services on our behalf consistent with our investment policies and objectives. Our advisor performed its duties and responsibilities under the Advisory Agreement as our fiduciary. Prior to the Merger, our advisor was 75.0% owned and managed by wholly owned subsidiaries of American Healthcare Investors, LLC, or American Healthcare Investors, and 25.0% owned by a wholly owned subsidiary of Griffin Capital Company, LLC, or Griffin Capital, or collectively, our co-sponsors. American Healthcare Investors was 47.1% owned by AHI Group Holdings, LLC, or AHI Group Holdings, 45.1% indirectly owned by Digital Bridge Group, Inc. (NYSE: DBRG) (formerly known as Colony Capital, Inc.), or Digital Bridge, and 7.8% owned by James F. Flaherty III, a former partner of Colony Capital, Inc. We were not affiliated with Griffin Capital, Griffin Capital Securities, LLC, or our dealer manager, Digital Bridge or Mr. Flaherty; however, we were affiliated with our advisor, American Healthcare Investors and AHI Group Holdings. Please see the “Merger with Griffin-American Healthcare REIT III, Inc.” and “AHI Acquisition” sections below for a further discussion of our operations effective October 1, 2021.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We operate through four reportable business segments: medical office buildings, senior housing, senior housing — RIDEA and skilled nursing facilities. As of September 30, 2021, we owned 87 properties, comprising 92 buildings, or approximately 4,799,000 square feet of gross leasable area, or GLA, for an aggregate contract purchase price of $1,080,381,000. As of September 30, 2021, we also owned a 6.0% interest in a joint venture which owned a portfolio of integrated senior health campuses and ancillary businesses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Due to the ongoing coronavirus, or COVID-19, pandemic in the United States and globally, since March 2020, our residents, tenants, operating partners and managers have been materially impacted, and the prolonged economic impact remains </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">uncertain. As the COVID-19 pandemic is still impacting the healthcare system to a degree, it continues to present challenges for us as an owner and operator of healthcare facilities. Since its outset, the impacts of the COVID-19 pandemic have been significant, rapidly and continuously evolving and may continue into the future, especially due to the emergence of the Delta variant which has caused COVID-19 cases and deaths to increase significantly in recent months, making it difficult to ascertain the long-term impact the COVID-19 pandemic will have on real estate markets in which we own and/or operate properties and our portfolio of investments. We have evaluated the impacts of the COVID-19 pandemic on our business thus far and incorporated information concerning the impact of COVID-19 into our assessments of liquidity, impairment and collectability from tenants and residents as of September 30, 2021. We will continue to monitor such impacts and will adjust our estimates and assumptions based on the best available information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Merger with Griffin-American Healthcare REIT III, Inc. </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 23, 2021, we, our operating partnership, our wholly owned subsidiary, Continental Merger Sub, LLC, or merger sub, Griffin-American Healthcare REIT III, Inc., or GAHR III, and American Healthcare REIT Holdings, LP (formerly known as Griffin-American Healthcare REIT III Holdings, LP), or the surviving partnership, entered into an Agreement and Plan of Merger, or the Merger Agreement. On October 1, 2021, pursuant to the Merger Agreement, (i) GAHR III merged with and into merger sub, with merger sub being the surviving company, or the REIT Merger, and (ii) our operating partnership merged with and into the surviving partnership, with the surviving partnership being the surviving entity and being renamed American Healthcare REIT Holdings, LP, or the Partnership Merger, and, together with the REIT Merger, the Merger. As a result of and at the effective time of the Merger, the separate corporate existence of GAHR III and our operating partnership ceased. </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Following the Merger, our company, combined with GAHR III, or the Combined Company, was renamed “American Healthcare REIT, Inc.” The REIT Merger is intended to qualify as a “reorganization” under, and within the meaning of, Section 368(a) of the Code.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:109%">AHI Acquisition</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Also on June 23, 2021, the surviving partnership, our co-sponsors, Platform Healthcare Investor T-II, LLC, Flaherty Trust, Jeffrey T. Hanson, our former Chief Executive Officer and Chairman of the Board of Directors, Danny Prosky, our President and former Chief Operating Officer, and Mathieu B. Streiff, our former Executive Vice President, General Counsel, entered into a contribution and exchange agreement, or the Contribution Agreement, pursuant to which, among other things, the surviving partnership agreed to acquire a newly formed entity, or NewCo, which we refer to as the AHI Acquisition, that owned substantially all of the business and operations of one of our co-sponsors, American Healthcare Investors, as well as all of the equity interests in (i) Griffin-American Healthcare REIT III Advisor, LLC, or GAHR III Advisor, a subsidiary of American Healthcare Investors that served as the external advisor of GAHR III, and (ii) our advisor. On October 1, 2021, the AHI Acquisition closed immediately prior to the consummation of the Merger. Following the consummation of the Merger, the Combined Company has become a self-managed company. </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> The AHI Acquisition will be treated as a business combination for accounting purposes, with GAHR III as both the legal and accounting acquiror of NewCo. While we are the legal acquiror of GAHR III in the REIT Merger, GAHR III was determined to be the accounting acquiror in the REIT Merger transaction in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, after considering the relative share ownership and the composition of the governing body of the Combined Company. As a result of the completion of the Merger and the AHI Acquisition, the historical information regarding our company’s structure, agreements and financial information presented within this Note 1 and throughout the rest of the Notes to Condensed Consolidated Financial Statements has materially changed; however, such information did apply to us as of September 30, 2021. See Note 20, Subsequent Events — Merger with Griffin-American Healthcare REIT III, Inc. and AHI Acquisition, for a further discussion about the Merger and the AHI Acquisition.</span></div>
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
3253535 shares
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
31021000 USD
CY2017 ahr Advisory Agreement Term
AdvisoryAgreementTerm
P1Y
CY2017 ahr Advisory Agreement Term
AdvisoryAgreementTerm
P1Y
CY2021Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
ahr Numberof Properties Acquiredfrom Unaffiliated Parties
NumberofPropertiesAcquiredfromUnaffiliatedParties
87 Property
ahr Number Of Buildings Acquired From Unaffiliated Parties
NumberOfBuildingsAcquiredFromUnaffiliatedParties
92 Building
CY2021Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
4799000 sqft
ahr Acquisition Aggregated Cost Of Acquired Properties Purchase Price
AcquisitionAggregatedCostOfAcquiredPropertiesPurchasePrice
1080381000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the disclosure of contingent assets and liabilities, at the date of our condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the initial and recurring valuation of certain assets acquired and liabilities assumed through property acquisitions, revenues and grant income, allowance for credit losses, impairment of long-lived and intangible assets and contingencies. These estimates are made and evaluated on an on-going basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in material adverse ways, and those estimates could be different under different assumptions or conditions.</span></div>
us-gaap Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts
FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tenant and Resident Receivables and Allowances</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Resident receivables, which are related to resident fees and services, are carried net of an allowance for credit losses. An allowance is maintained for estimated losses resulting from the inability of residents and payors to meet the contractual obligations under their lease or service agreements. Substantially all of such allowances are recorded as direct reductions of resident fees and services revenue as contractual adjustments provided to third-party payors or implicit price concessions in our accompanying condensed consolidated statements of operations. Our determination of the adequacy of these allowances is based primarily upon evaluations of historical loss experience, the residents’ financial condition, security deposits, cash collection patterns by payor and by state, current economic conditions, future expectations in estimating credit losses and other relevant factors. Tenant receivables, which are related to real estate revenue, and unbilled deferred rent receivables are reduced for uncollectible amounts, which are recognized as direct reductions of real estate revenue in our accompanying condensed consolidated statements of operations.</span></div>
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2219000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2086000 USD
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
839000 USD
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
937000 USD
ahr Financing Receivable Allowancefor Credit Loss Collectionsor Adjustments
FinancingReceivableAllowanceforCreditLossCollectionsorAdjustments
-350000 USD
ahr Financing Receivable Allowancefor Credit Loss Collectionsor Adjustments
FinancingReceivableAllowanceforCreditLossCollectionsorAdjustments
-126000 USD
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
356000 USD
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
60000 USD
CY2021Q3 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1011829000 USD
CY2020Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1002859000 USD
CY2021Q3 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
104726000 USD
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
81279000 USD
CY2021Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
907103000 USD
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
921580000 USD
CY2021Q3 us-gaap Depreciation
Depreciation
8181000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
7966000 USD
us-gaap Depreciation
Depreciation
24025000 USD
us-gaap Depreciation
Depreciation
23698000 USD
ahr Capitalized Acquisition Costsand Fees Additions
CapitalizedAcquisitionCostsandFeesAdditions
94000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-184000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
54752000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
64101000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2358000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4728000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9495000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14361000 USD
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P8Y9M18D
CY2020 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P8Y9M18D
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2396000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
8647000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
7390000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
6195000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5017000 USD
CY2021Q3 ahr Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
24759000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
54404000 USD
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
45627000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
46653000 USD
CY2021Q3 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
15101000 USD
CY2020Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
12395000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
3939000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
9028000 USD
CY2021Q3 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
687000 USD
CY2020Q4 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
426000 USD
CY2021Q3 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
3763000 USD
CY2020Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
2399000 USD
CY2021Q3 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
4808000 USD
CY2020Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
3397000 USD
CY2021Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
313000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1724000 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
68743000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
72199000 USD
CY2021Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
470000 USD
CY2020Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
471000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1411000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1410000 USD
CY2021Q3 ahr Joint Ventureunamortizedbasisdifference
JointVentureunamortizedbasisdifference
16448000 USD
CY2020Q4 ahr Joint Ventureunamortizedbasisdifference
JointVentureunamortizedbasisdifference
16791000 USD
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
18291000 USD
CY2021Q3 us-gaap Secured Debt
SecuredDebt
17409000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
18766000 USD
CY2020Q4 us-gaap Secured Debt
SecuredDebt
17827000 USD
CY2021Q3 ahr Number Of Fixed Rate Mortgage Loans Payable
NumberOfFixedRateMortgageLoansPayable
3 MortgageLoan
CY2020Q4 ahr Number Of Fixed Rate Mortgage Loans Payable
NumberOfFixedRateMortgageLoansPayable
3 MortgageLoan
CY2020Q1 ahr Payoffofmortgageloanpayable
Payoffofmortgageloanpayable
7738000 USD
CY2020Q4 us-gaap Secured Debt
SecuredDebt
17827000 USD
CY2019Q4 us-gaap Secured Debt
SecuredDebt
26070000 USD
ahr Amortizationofdeferredfinancingcostsrelatedtomortgage
Amortizationofdeferredfinancingcostsrelatedtomortgage
20000 USD
ahr Amortizationofdeferredfinancingcostsrelatedtomortgage
Amortizationofdeferredfinancingcostsrelatedtomortgage
33000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-37000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-37000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
475000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
8166000 USD
CY2021Q3 us-gaap Secured Debt
SecuredDebt
17409000 USD
CY2020Q3 us-gaap Secured Debt
SecuredDebt
17974000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
132000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
651000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
680000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
711000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
5878000 USD
CY2021Q3 ahr Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
10239000 USD
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
18291000 USD
CY2018Q4 ahr Line Of Credit Facility Number Of Potential Extensions
LineOfCreditFacilityNumberOfPotentialExtensions
1 Extension
CY2018Q4 ahr Line Of Credit Facility Potential Extension Term
LineOfCreditFacilityPotentialExtensionTerm
P12M
CY2020Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
530000000 USD
CY2021Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
530000000 USD
CY2021Q3 us-gaap Line Of Credit
LineOfCredit
488900000 USD
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
476900000 USD
CY2021Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
1514000 USD
CY2020Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
1450000 USD
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
4431000 USD
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-2302000 USD
CY2021Q3 ahr Amortizationof Identified Intangible Liabilities
AmortizationofIdentifiedIntangibleLiabilities
59000 USD
CY2020Q3 ahr Amortizationof Identified Intangible Liabilities
AmortizationofIdentifiedIntangibleLiabilities
78000 USD
ahr Amortizationof Identified Intangible Liabilities
AmortizationofIdentifiedIntangibleLiabilities
181000 USD
ahr Amortizationof Identified Intangible Liabilities
AmortizationofIdentifiedIntangibleLiabilities
239000 USD
ahr Finite Lived Intangible Liabilities Useful Life
FiniteLivedIntangibleLiabilitiesUsefulLife
P12Y
CY2020 ahr Finite Lived Intangible Liabilities Useful Life
FiniteLivedIntangibleLiabilitiesUsefulLife
P11Y7M6D
CY2021Q3 ahr Finite Lived Intangible Liabilities Amortization Expenses Remainder Of Fiscal Year
FiniteLivedIntangibleLiabilitiesAmortizationExpensesRemainderOfFiscalYear
55000 USD
CY2021Q3 ahr Finite Lived Intangible Liabilities Amortization Expenses Year Two
FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearTwo
217000 USD
CY2021Q3 ahr Finite Lived Intangible Liabilities Amortization Expenses Year Three
FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearThree
207000 USD
CY2021Q3 ahr Finite Lived Intangible Liabilities Amortization Expenses Year Four
FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFour
161000 USD
CY2021Q3 ahr Finite Lived Intangible Liabilities Amortization Expenses Year Five
FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFive
123000 USD
CY2021Q3 ahr Finite Lived Intangible Liabilities Amortization Expenses After Year Five
FiniteLivedIntangibleLiabilitiesAmortizationExpensesAfterYearFive
352000 USD
CY2021Q3 ahr Finite Lived Intangible Liabilities Net
FiniteLivedIntangibleLiabilitiesNet
1115000 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
2618000 USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
1462000 USD
ahr Proceedsfromredeemablenoncontrollinginterest
Proceedsfromredeemablenoncontrollinginterest
125000 USD
ahr Proceedsfromredeemablenoncontrollinginterest
Proceedsfromredeemablenoncontrollinginterest
1118000 USD
ahr Paymentsto Redeemable Noncontrolling Interest
PaymentstoRedeemableNoncontrollingInterest
8000 USD
ahr Paymentsto Redeemable Noncontrolling Interest
PaymentstoRedeemableNoncontrollingInterest
81000 USD
ahr Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests
AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests
167000 USD
ahr Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests
AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests
530000 USD
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-310000 USD
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-332000 USD
CY2021Q3 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
2592000 USD
CY2020Q3 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
2697000 USD
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
8177085 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
105000 shares
ahr Common Stock Repurchased During Period Under Share Repurchase Plan Shares
CommonStockRepurchasedDuringPeriodUnderShareRepurchasePlanShares
2211338 shares
CY2021Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
0 USD
CY2020Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
4247000 USD
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
5499000 USD
us-gaap Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan
ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan
77991000 USD
us-gaap Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan
ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan
72492000 USD
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
8177085 shares
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
7595594 shares
ahr Maximum Percentage Of Common Stock Repurchased During Period
MaximumPercentageOfCommonStockRepurchasedDuringPeriod
0.050
CY2021Q3 ahr Share Repurchase Plan Percentageof Priceper Share Condition Two
ShareRepurchasePlanPercentageofPriceperShareConditionTwo
1
CY2020Q3 ahr Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
9.87
ahr Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
9.88
ahr Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
9.25
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
2211338 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
2021771 shares
ahr Stock Repuchased During Period Value Under Share Repurchase Plan Value
StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue
20744000 USD
ahr Stock Repuchased During Period Value Under Share Repurchase Plan Value
StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue
18870000 USD
ahr Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
9.38
ahr Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
9.33
CY2021Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
3129000 USD
CY2020Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
3045000 USD
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
9574000 USD
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
10344000 USD
CY2021Q3 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
324000 USD
CY2020Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
1046000 USD
CY2021Q3 us-gaap Secured Debt
SecuredDebt
17409000 USD
CY2021Q3 us-gaap Loans Payable Fair Value Disclosure
LoansPayableFairValueDisclosure
20891000 USD
CY2020Q4 us-gaap Secured Debt
SecuredDebt
17827000 USD
CY2020Q4 us-gaap Loans Payable Fair Value Disclosure
LoansPayableFairValueDisclosure
22052000 USD
CY2021Q3 ahr Linesofcreditandtermloannet
Linesofcreditandtermloannet
488587000 USD
CY2021Q3 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
488995000 USD
CY2020Q4 ahr Linesofcreditandtermloannet
Linesofcreditandtermloannet
475176000 USD
CY2020Q4 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
477651000 USD
CY2021Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
914000 USD
CY2020Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
863000 USD
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2717000 USD
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2134000 USD
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
791000 USD
CY2021Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
232000 USD
CY2020Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
327000 USD
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
721000 USD
CY2021Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-37000 USD
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-2000 USD
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1146000 USD
CY2020Q3 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1190000 USD
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3508000 USD
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2855000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-39000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
22120000 USD
CY2020Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
21519000 USD
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
5013000 USD
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
4592000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
66054000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
64824000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
14817000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
13861000 USD
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
16361000 USD
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
64121000 USD
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
60213000 USD
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
49138000 USD
CY2021Q3 ahr Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
283142000 USD
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
54662000 USD
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
527637000 USD
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
226000 USD
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
206000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
644000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
643000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P78Y8M12D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P79Y6M
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0574
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0574
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
213000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
526000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
530000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
534000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
538000 USD
CY2021Q3 ahr Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
46565000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
48906000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
38885000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
10021000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2021Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
22120000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-39000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-5152000 USD
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
66054000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15090000 USD
CY2021Q3 us-gaap Revenues
Revenues
37210000 USD
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
6389000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14540000 USD
CY2021Q3 ahr Segmentnetoperatingincome
Segmentnetoperatingincome
16281000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4304000 USD
CY2021Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3800000 USD
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10746000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
4961000 USD
CY2021Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
1514000 USD
CY2021Q3 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
15000 USD
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
70000 USD
CY2021Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
33000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3329000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-5898000 USD
CY2020Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
21519000 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
5905000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18948000 USD
CY2020Q3 ahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
864000 USD
CY2020Q3 ahr Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
41331000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17397000 USD
CY2020Q3 ahr Segmentnetoperatingincome
Segmentnetoperatingincome
18029000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3672000 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
57000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12669000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
4839000 USD
CY2020Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
1450000 USD
CY2020Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
3064000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-377000 USD
CY2020Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
8000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6822000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5191000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46179000 USD
us-gaap Revenues
Revenues
112233000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
18542000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
44179000 USD
ahr Segmentnetoperatingincome
Segmentnetoperatingincome
49512000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11710000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6552000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
33745000 USD
us-gaap Interest Expense
InterestExpense
14556000 USD
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
4431000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-184000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1027000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
49000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11287000 USD
us-gaap Profit Loss
ProfitLoss
-13782000 USD
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
64824000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51863000 USD
ahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
864000 USD
ahr Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
117551000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
17723000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
44856000 USD
ahr Segmentnetoperatingincome
Segmentnetoperatingincome
54972000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11960000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
74000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
37919000 USD
us-gaap Interest Expense
InterestExpense
15123000 USD
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-2302000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
3064000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
952000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
278000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19259000 USD
us-gaap Profit Loss
ProfitLoss
-14240000 USD
us-gaap Profit Loss
ProfitLoss
-14240000 USD
CY2021Q3 us-gaap Assets
Assets
1063896000 USD
CY2020Q4 us-gaap Assets
Assets
1092773000 USD
CY2021Q3 ahr Concentration Risk Number Of States That Generated At Least Ten Percent Of Annualized Base Rent
ConcentrationRiskNumberOfStatesThatGeneratedAtLeastTenPercentOfAnnualizedBaseRent
2 State
CY2021Q3 ahr Minimum Percent Share Of Each State Annualized Base Rent That Company Owned
MinimumPercentShareOfEachStateAnnualizedBaseRentThatCompanyOwned
0.100
CY2021Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2021Q3 ahr Number Of Tenants With More Than Ten Percent Of Annual Base Rent
NumberOfTenantsWithMoreThanTenPercentOfAnnualBaseRent
1 tenant
CY2021Q3 ahr Minimum Percent Share Of Annualized Base Rent Accounted By Tenants
MinimumPercentShareOfAnnualizedBaseRentAccountedByTenants
0.100
CY2021Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
3000 USD
CY2020Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
4000 USD
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
12000 USD
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
15000 USD
CY2021Q3 ahr Share Repurchase Plan Percentageof Priceper Share Condition Four
ShareRepurchasePlanPercentageofPriceperShareConditionFour
1
CY2021Q3 ahr Number Of Board Of Directors
NumberOfBoardOfDirectors
5 facility

Files In Submission

Name View Source Status
0001632970-21-000113-index-headers.html Edgar Link pending
0001632970-21-000113-index.html Edgar Link pending
0001632970-21-000113.txt Edgar Link pending
0001632970-21-000113-xbrl.zip Edgar Link pending
ahr-20210930.htm Edgar Link pending
ahr-20210930.xsd Edgar Link pending
ahr-20210930_cal.xml Edgar Link unprocessable
ahr-20210930_def.xml Edgar Link unprocessable
ahr-20210930_htm.xml Edgar Link completed
ahr-20210930_lab.xml Edgar Link unprocessable
ahr-20210930_pre.xml Edgar Link unprocessable
ex105ahr2021xq3gahrivxamen.htm Edgar Link pending
ex108ahr2021xq3gahriiixame.htm Edgar Link pending
ex311-ahrx10xq2021xq3.htm Edgar Link pending
ex312-ahrx10xq2021xq3.htm Edgar Link pending
ex321-ahrx10xq2021xq3.htm Edgar Link pending
ex322-ahrx10xq2021xq3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending